版本:
中国

BRIEF-Navidea achieves $1 mln in Lymphoseek commercial milestones

Sept 22 Navidea Biopharmaceuticals Inc

* Navidea achieves $1 million in Lymphoseek commercial milestones

* Navidea to receive $500,000 payment from SpePharm AG, an affiliate of Norgine, B.V., for EMA approval of Lymphoseek single dose vial Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐